, company and subsidiaries had total revenue for nine months as at september30, 2019, Q3/2019 and Q3/2018 at Baht 166.34 million, and Baht 163.93 million respectively. The increase of Baht 2.41 million is
, company and subsidiaries had total revenue for nine months as at september30, 2019, Q3/2019 and Q3/2018 at Baht 166.34 million, and Baht 163.93 million respectively. The increase of Baht 2.41 million is
/19”) sales revenue of Baht 3,199.32 million. The drop in sales revenue was mainly as a result of significant drop in Total Industry Volume (“TIV”) and Total Industry Production (“TIP”) for Thailand
asset held for sale 3 - n.a. Finance Cost 8 4 200 Profit (Loss) before Tax income (expense) (39) 46 (184) Tax Income (Expense) 2 7 (71) Net Profit (41) 39 (205) - 2 - Total Revenues In the three-month
cost control. Financing Cost The financing cost was barely zero during 2Q20. Net Profit 2Q20 net profit increased by 34% yoy. Since 2Q19 net profit has been affected by non- recurring items for the total
of other comprehensive - (1) -100 Finance Cost 7 5 40 Profit (Loss) before Tax income (expense) 5 56 -91 Tax Income (Expense) (1) (8) 88 Net Profit 4 48 -92 - 2 - Total Revenues In the three-month
reported total revenues in 2Q20 of THB 118.89 million, a 45.24 percent decrease from 2Q19 revenues of THB 217.12 million. Loss attributable to equity holders of the Company of THB 0.22 million compared to
97.68 -15% % Net Profit / Total Revenue 18% 32% -14% % Net Profit excl. Disposal of Land / Revenue from Hospital Operations 19% 22% -3% Non-Controlling Interests 0.15 0.26 -43% Net Profit Attributable to
subsidiaries for the three- month period ended March 31, 2020. The Company would like to clarify on the operating results as follows: Revenue • For Q1/ 2020, total consolidated revenues advanced to Baht 424.91
margin in the first quarter of the year 2020 and 2019 are 28.27% and 27.08% respectively similarity. But as a result of administrative expenses, most of which are fixed expenses, the total operating for